140 related articles for article (PubMed ID: 29113307)
1. Prediction of clinical outcome and survival in soft-tissue sarcoma using a ten-lncRNA signature.
He RQ; Wei QJ; Tang RX; Chen WJ; Yang X; Peng ZG; Hu XH; Ma J; Chen G
Oncotarget; 2017 Oct; 8(46):80336-80347. PubMed ID: 29113307
[TBL] [Abstract][Full Text] [Related]
2. A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma.
Mao X; Qin X; Li L; Zhou J; Zhou M; Li X; Xu Y; Yuan L; Liu QN; Xing H
Gynecol Oncol; 2018 Apr; 149(1):181-187. PubMed ID: 29525275
[TBL] [Abstract][Full Text] [Related]
3. A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma.
Shi D; Qu Q; Chang Q; Wang Y; Gui Y; Dong D
Oncotarget; 2017 Aug; 8(35):58699-58708. PubMed ID: 28938589
[TBL] [Abstract][Full Text] [Related]
4. Genetic landscape of long noncoding RNA (lncRNAs) in glioblastoma: identification of complex lncRNA regulatory networks and clinically relevant lncRNAs in glioblastoma.
Paul Y; Thomas S; Patil V; Kumar N; Mondal B; Hegde AS; Arivazhagan A; Santosh V; Mahalingam K; Somasundaram K
Oncotarget; 2018 Jul; 9(51):29548-29564. PubMed ID: 30038703
[TBL] [Abstract][Full Text] [Related]
5. Survival prediction of kidney renal papillary cell carcinoma by comprehensive LncRNA characterization.
Lan H; Zeng J; Chen G; Huang H
Oncotarget; 2017 Dec; 8(67):110811-110829. PubMed ID: 29340018
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Clinical Outcome in Endometrial Carcinoma Based on a 3-lncRNA Signature.
Ding H; Jiang F; Deng L; Wang J; Wang P; Ji M; Li J; Shi W; Pei Y; Li J; Zhang Y; Zhang Z; Chen Y; Li B
Front Cell Dev Biol; 2021; 9():814456. PubMed ID: 35178403
[TBL] [Abstract][Full Text] [Related]
7. A novel prognostic cancer-related lncRNA signature in papillary renal cell carcinoma.
Chen B; Dong D; Yao Q; Zou Y; Hu W
Cancer Cell Int; 2021 Oct; 21(1):545. PubMed ID: 34663322
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of a novel four-lncRNA signature as a prognostic biomarker for human gastric cancer.
Miao Y; Sui J; Xu SY; Liang GY; Pu YP; Yin LH
Oncotarget; 2017 Sep; 8(43):75007-75024. PubMed ID: 29088841
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of competing endogenous RNA network revealing lncRNAs as potential prognostic biomarkers in human lung squamous cell carcinoma.
Sui J; Xu SY; Han J; Yang SR; Li CY; Yin LH; Pu YP; Liang GY
Oncotarget; 2017 Sep; 8(39):65997-66018. PubMed ID: 29029488
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles analysis of long non-coding RNAs identified novel lncRNA biomarkers with predictive value in outcome of cutaneous melanoma.
Ma X; He Z; Li L; Yang D; Liu G
Oncotarget; 2017 Sep; 8(44):77761-77770. PubMed ID: 29100423
[TBL] [Abstract][Full Text] [Related]
11. A six-long non-coding RNAs signature as a potential prognostic marker for survival prediction of ER-positive breast cancer patients.
Zhong L; Lou G; Zhou X; Qin Y; Liu L; Jiang W
Oncotarget; 2017 Sep; 8(40):67861-67870. PubMed ID: 28978079
[TBL] [Abstract][Full Text] [Related]
12. A six-long non-coding RNA signature predicts prognosis in melanoma patients.
Yang S; Xu J; Zeng X
Int J Oncol; 2018 Apr; 52(4):1178-1188. PubMed ID: 29436619
[TBL] [Abstract][Full Text] [Related]
13. Expression profiles analysis reveals an integrated miRNA-lncRNA signature to predict survival in ovarian cancer patients with wild-type BRCA1/2.
Guo L; Peng Y; Meng Y; Liu Y; Yang S; Jin H; Li Q
Oncotarget; 2017 Sep; 8(40):68483-68492. PubMed ID: 28978132
[TBL] [Abstract][Full Text] [Related]
14. A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma.
Zhang H; Zhu M; Du Y; Zhang H; Zhang Q; Liu Q; Huang Z; Zhang L; Li H; Xu L; Zhou X; Zhu W; Shu Y; Liu P
J Cancer; 2019; 10(6):1550-1559. PubMed ID: 31031865
[No Abstract] [Full Text] [Related]
15. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
[TBL] [Abstract][Full Text] [Related]
16. A long non-coding RNA signature in glioblastoma multiforme predicts survival.
Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK
Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844
[TBL] [Abstract][Full Text] [Related]
17. A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma.
Zhou C; Wang S; Zhou Q; Zhao J; Xia X; Chen W; Zheng Y; Xue M; Yang F; Fu D; Yin Y; Atyah M; Qin L; Zhao Y; Bruns C; Jia H; Ren N; Dong Q
Front Oncol; 2019; 9():1160. PubMed ID: 31781487
[No Abstract] [Full Text] [Related]
18. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
[TBL] [Abstract][Full Text] [Related]
19. A long non-coding RNA signature for predicting survival in patients with colorectal cancer.
Wang YL; Shao J; Wu X; Li T; Xu M; Shi D
Oncotarget; 2018 Apr; 9(31):21687-21695. PubMed ID: 29774095
[TBL] [Abstract][Full Text] [Related]
20. Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma.
Shi X; Zhao Y; He R; Zhou M; Pan S; Yu S; Xie Y; Li X; Wang M; Guo X; Qin R
Oncotarget; 2018 May; 9(36):24248-24259. PubMed ID: 29849937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
